Home › Kanser ng Endometrium › Ohio › Columbus

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Columbus, OH

Isang pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Nagre-recruitPhase 3

Ohio State University Comprehensive Cancer Center, Columbus
Columbus Oncology and Hematology Associates Inc, Columbus
Riverside Methodist Hospital, Columbus
at 8 pa

Edad 18 pataas · Kababaihan · Na-update Okt 5, 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Ohio State University Comprehensive Cancer Center, Columbus
Mount Carmel East Hospital, Columbus
Columbus Oncology and Hematology Associates Inc, Columbus
at 13 pa

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Nagre-recruitPhase 1/2

Research Site, Columbus

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05797168

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Nagre-recruitPhase 1

Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT05950464

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Nagre-recruitPhase 2

Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Nagre-recruitPhase 1/2

The Ohio State University Wexner Medical Center, Columbus

Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT03564340

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Nagre-recruitPhase 2

Ohio State University Comprehensive, Columbus

Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Nagre-recruitPhase 1/2

The Ohio State University Wexner Medical Center, Columbus

Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT04590326

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Nagre-recruitPhase 2

Research Site, Columbus

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05489211

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Nagre-recruitPhase 3

Ohio State University, Hilliard · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06340568

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Nagre-recruitPhase 3

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Nagre-recruitPhase 1

The Ohio State University (OSU) Wexner Medical Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06400472

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Nagre-recruitPhase 3

Research Site, Columbus

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Nagre-recruitPhase 1

The Ohio State University, Columbus

Edad 15 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06276491

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Nagre-recruitPhase 2

Ohio State University, Hilliard · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Ago 21, 2026 · NCT05548296

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Nagre-recruitPhase 1

Ohio State University Wexner Medical Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07470853

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

The Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Nagre-recruitPhase 3

Research Site, Columbus
Research Site, Hilliard · 10 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Stefanie Spielman Comprehensive Breast Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

A Study of LY4175408 in Participants With Advanced Cancer

Nagre-recruitPhase 1

The Ohio State University (OSU) Wexner Medical Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Stefanie Spielman Comprehensive Breast Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06395519

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Nagre-recruitPhase 1/2

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Columbus

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Nagre-recruitPhase 2/3

OhioHealth Institute, Columbus

Edad 18 pataas · Kababaihan · Na-update May 2, 2024 · NCT05797831

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Columbus

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.